August 18, 2023 (Earnings Report) Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Fabrinet
Symbol: FN
Recent Price: $116.23
Average Analyst Price Target: $138.00 (33.36%)
Market Cap: $4.23B
Last Year's EPS: 1.9
Consensus EPS Forecast: 1.87
Expected Earnings Date: 2023-05-08
Recent Analyst Action: Samik Chatterjee, analyst at J.P. Morgan, reiterates coverage on Fabrinet (FN) in the Technology sector with a Buy rating and a price target of $160 (4 weeks ago).
TipRanks.com also reports that Fabrinet currently has 14 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $138.00 . The target pricing ranges from a high forecast of $156.00 down to a low forecast of $100.00. Fabrinet (FN)’s last closing price was $116.23 which would put the average price target at 33.36% upside.Here are 3rd party ratings for FN:
Recent Analyst Action: William Power, analyst at Robert W. Baird, reiterates coverage on Zoom Video Communications (ZM) in the Technology sector with a Buy rating and a price target of $95 (2 days ago).
TipRanks.com also reports that Zoom Video Communications currently has 13 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $138.97 . The target pricing ranges from a high forecast of $295.00 down to a low forecast of $76.00. Zoom Video Communications (ZM)’s last closing price was $65.63 which would put the average price target at 27.88% upside.Here are 3rd party ratings for ZM:
Recent Analyst Action: Ben Davis, analyst at Liberum Capital, reiterates coverage on BHP Group (BHP) in the Basic Materials sector with a Hold rating and a price target of n/a (1 month ago).
TipRanks.com also reports that BHP Group currently has analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is . The target pricing ranges from a high forecast of down to a low forecast of . BHP Group (BHP)’s last closing price was $55.69 which would put the average price target at 27.14% upside.Here are 3rd party ratings for BHP:
Recent Analyst Action: Howard Halpern, analyst at Taglich Brothers, reiterates coverage on Tingo Group (TIO) in the Technology sector with a Buy rating and a price target of $11.75 (3 months ago).
TipRanks.com also reports that Tingo Group currently has analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is . The target pricing ranges from a high forecast of down to a low forecast of . Tingo Group (TIO)’s last closing price was $1.22 which would put the average price target at 867.08% upside.Here are 3rd party ratings for TIO:
Recent Analyst Action: Robert LeBoyer, analyst at Noble Financial, reiterates coverage on MAIA Biotechnology, Inc. (MAIA) in the Healthcare sector with a Buy rating and a price target of $14 (1 week ago).
TipRanks.com also reports that MAIA Biotechnology, Inc. currently has analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is . The target pricing ranges from a high forecast of down to a low forecast of . MAIA Biotechnology, Inc. (MAIA)’s last closing price was $1.82 which would put the average price target at 669.23% upside.Here are 3rd party ratings for MAIA:
Recent Analyst Action: Emily Bodnar, analyst at H.C. Wainwright, reiterates coverage on TransCode Therapeutics (RNAZ) in the Healthcare sector with a Buy rating and a price target of $12 (3 days ago).
TipRanks.com also reports that TransCode Therapeutics currently has analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is . The target pricing ranges from a high forecast of down to a low forecast of . TransCode Therapeutics (RNAZ)’s last closing price was $1.58 which would put the average price target at 659.49% upside.Here are 3rd party ratings for RNAZ:
Recent Analyst Action: Daley Li, analyst at Bank of America Securities, reiterates coverage on Agora (API) in the Technology sector with a Buy rating and a price target of $4.5 (3 weeks ago).
TipRanks.com also reports that Agora currently has 13 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $12.50 . The target pricing ranges from a high forecast of $12.50 down to a low forecast of $12.50. Agora (API)’s last closing price was $2.84 which would put the average price target at 60.21% upside.Here are 3rd party ratings for API:
To Your Financial Future,
The Editor, WallStreetSectors.com